Drugs News and Research

RSS

BMJ examines new strategy for universal healthcare in Asia Pacific

A BMJ News article examines a new strategy, which was released at the 60th session of WHO's regional committee for the Western Pacific, calling for countries in the Asia Pacific region to "strive for universal access to health care."

1 Oct 2009

GAO: Medicaid wastes millions on phony prescriptions for painkillers

A new report by the Government Accountability Office "finds that state and federal officials failed to detect millions of dollars in Medicaid prescription drug abuse," USA Today reports. "An audit of the government program in five large states found about 65,000 instances of beneficiaries improperly obtaining potentially addictive drugs at a cost of about $65 million during 2006 and 2007 — including thousands of prescriptions written for dead patients or by people posing as doctors."

30 Sep 2009

Orphan drug designation for pixantrone applied by Cell Therapeutics

Cell Therapeutics, Inc. ("CTI") announced today that it has applied to the European Medicines Agency (EMEA) for orphan drug designation for pixantrone. CTI initiated the process of obtaining marketing approval in Europe in July, 2009, for the treatment of relapsed or refractory aggressive NHL.

30 Sep 2009

First telemedicine-assisted video laryngoscopic intubation using GlideScope Video Laryngoscope

The Department of Emergency Medicine at The University of Arizona College of Medicine Tucson, led by Dr. John C. Sakles, recently performed the first telemedicine-assisted video laryngoscopic intubation using the GlideScope Video Laryngoscope to assist Northern Cochise Community Hospital, a small, rural healthcare facility in Southern Arizona.

30 Sep 2009

IDRI and Academia Sinica sign Memorandum of Understanding

On behalf of The Lilly TB Drug Discovery Initiative, the Infectious Disease Research Institute (IDRI) today signed a Memorandum of Understanding (MOU) with Academia Sinica, a research institution based in Taiwan, to collaborate in target-based screening for the discovery of new tuberculosis (TB) drugs.

30 Sep 2009

New center for gastrointestinal cancer research established

Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.

30 Sep 2009

FDA's Structured Product Labeling to be discussed

The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their forum on FDA's Structured Product Labeling (SPL R4). The inaugural program will be chaired by Theresa Brunone, Assistant Director, GlaxoSmithKline. The conference will take place in Washington, DC, on December 8-9, 2009.

30 Sep 2009

SATAI invests $1.045 million in Azaya Therapeutics

SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya’s proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.

30 Sep 2009

Ontario's doctors to stress the importance of health care professionals working together to the Standing Committee

At an appearance today before the Ontario Legislative Standing Committee on Social Policy, Ontario's doctors will stress the importance of health care professionals working together to enhance and strengthen the delivery of safe and quality care to patients.

30 Sep 2009

Savvion and Patni partner to deliver BPM-enabled solutions

Savvion® and Patni Life Sciences announced today a strategic partnership to jointly deliver Business Process Management (BPM)-enabled solutions for clinical operations on top of Savvion’s Life Sciences Foundation.

30 Sep 2009

Opinion: 'Microland' to fight poverty; ensuring quality, timely drugs for Africa

In a Forbes column, Elisabeth Eaves, deputy editor at Forbes, examines the concept of "'microland:' securing rights to small plots of land for the world's poorest."

30 Sep 2009

Researchers find new ways to treat Myelodysplastic Syndrome

Van Andel Research Institute (VARI) researchers are one step closer to finding new ways to treat Myelodysplastic Syndrome (MDS), a bone marrow disease that strikes up to 15,000 people each year in the United States, and that sometimes results in acute myeloid leukemia.

30 Sep 2009

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.

30 Sep 2009

Is using health resources less expensively "rationing?"

Critics of the Democrats' health care overhaul effort see veiled "rationing" schemes behind plans to curb misused and overused tests, treatments and drugs that drive up medical costs without helping patients, The Washington Post reports.

30 Sep 2009

Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today the availability of its ResponseDX: Gastric™ genetic test panel, a proprietary PCR-based diagnostic test. By analyzing the expression of genes that correlate with response to commonly used chemotherapy agents, physicians can better tailor treatment for their patients with gastric cancer and gastroesophageal (GE) junction cancer.

29 Sep 2009

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.

29 Sep 2009

Local officials address long-term costs associated with employee and retiree health care

About 49 percent of the nations’ cities, counties and townships expect less revenue in 2010, and 21 percent expect fewer employees, according to a new survey.

29 Sep 2009

Sciele Pharma files NDA for glycopyrrolate oral solution

Sciele Pharma, Inc., a Shionogi company, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders.

29 Sep 2009

NHGRI and NIMH fund $45 million to establish Centers of Excellence in Genomic Science

The National Human Genome Research Institute (NHGRI) and National Institute of Mental Health (NIMH), both part of the National Institutes of Health, today announced grants expected to total approximately $45 million to establish new Centers of Excellence in Genomic Science at the Medical College of Wisconsin and University of North Carolina, Chapel Hill as well as to continue support of existing centers at Johns Hopkins University and the University of Southern California.

29 Sep 2009

AAPS Annual Meeting to discuss new research and technologies in pharmaceutical sciences

More than 8,500 individuals from the field of pharmaceutical research are expected to attend this year's AAPS Annual Meeting and Exposition November 8 - 12, 2009 at the Los Angeles Convention Center in California.

29 Sep 2009

Drugs News and Research

BMJ examines new strategy for universal healthcare in Asia Pacific

GAO: Medicaid wastes millions on phony prescriptions for painkillers

Orphan drug designation for pixantrone applied by Cell Therapeutics

First telemedicine-assisted video laryngoscopic intubation using GlideScope Video Laryngoscope

IDRI and Academia Sinica sign Memorandum of Understanding

New center for gastrointestinal cancer research established

FDA's Structured Product Labeling to be discussed

SATAI invests $1.045 million in Azaya Therapeutics

Ontario's doctors to stress the importance of health care professionals working together to the Standing Committee

Savvion and Patni partner to deliver BPM-enabled solutions

Opinion: 'Microland' to fight poverty; ensuring quality, timely drugs for Africa

Researchers find new ways to treat Myelodysplastic Syndrome

Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine

Is using health resources less expensively "rationing?"

Response Genetics launches new genetic diagnostic test for gastric cancer

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Local officials address long-term costs associated with employee and retiree health care

Sciele Pharma files NDA for glycopyrrolate oral solution

NHGRI and NIMH fund $45 million to establish Centers of Excellence in Genomic Science

AAPS Annual Meeting to discuss new research and technologies in pharmaceutical sciences

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News